Insider · CIK 0001901039
Susan Laura Smith
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing Mar 7, 2024, latest Mar 7, 2024.
In brief
Susan Laura Smith files SEC Form 4 as officer at YMAB (Y-mAbs Therapeutics, Inc.). Since Mar 7, 2024, Susan Laura Smith has reported 0 open-market buys worth $0 and 1 open-market sell worth $28k, the latest filed on Mar 7, 2024.
A track record needs three past buys with six months of prices behind them; Susan Laura Smith has 0, so none is measured yet.
The newest scored trade: sold $28k of YMAB on Mar 5, 2024, filed Mar 7, 2024, scored 35 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Y-mAbs Therapeutics, Inc. | $28k 1,682 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 7, 2025 | YMAB Y-mAbs Therapeutics, Inc. | 5,528 0.01% of outstanding | $29k | Mar 7, 2025 | none |
| Mar 6, 2024 | YMAB Y-mAbs Therapeutics, Inc. | 1,682 0.00% of outstanding | $28k | Mar 5, 2024 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | YMAB Y-mAbs Therapeutics, Inc. | SOpen-market sale Common Stock | -1,682 | $16.55 | $28k | 33,918 | Mar 7, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +17,800 | $0.00 | $0 | 35,600 | Jan 22, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +35,700 | $0.00 | $0 | 35,700 | Jan 22, 2024 |
Questions about Susan Laura Smith
Answered from the filings on this page, as of the latest one.
Is Susan Laura Smith buying or selling?
Not in the last 12 months. Susan Laura Smith's latest open-market trade on SEC Form 4 was sold $28k of YMAB on Mar 5, 2024.
How did Susan Laura Smith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan Laura Smith has 0.
Where does Susan Laura Smith file Form 4?
Susan Laura Smith has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.) as SVP & CHIEF COMMERCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.